|
Issue 12 – Summer 2010
Co-marketing – a successful cooperation model
Trends in pharmaceutical dealmaking
Plan B : When negotiations fail
Follow-on Biologics
Finding new products to license
Book review
Deal Watch
Read more HERE
|
|
Issue 11 - Spring 2010
New Oilfields in Pharma
Licensing Deal Valuation
A Revolution in Healthcare
Innovation in Negotiation
Paediatric Legislation – A Potential Roadblock to New Drugs in Europe
Deal Watch
Read more HERE
|
|
Issue 10 – IPLS 2009
The Development of Personalised Medicine
Survival of the Fittest: How the financial Crisis is Saving Big Pharma
Crating Value with Alliance Management
Difficult Negotiations with Difficult Negotiators
Pharma at the Crossroads
Read more HERE
|
|
Issue 9 – Autumn 2009
PLG News
European Commission Pharmaceutical Sector Inquiry
Managing Growth by Minimising Risk
Regulatory Data Exclusivity in the European Union
Diversified or Dead?
Negotiating with Governments
Evaluating Licensing Opportunities
Read more HERE
|
|
Issue 8 – Spring 2009
PLG News
Strategic options for getting the most out of late-stage licensing deals
Trends in the therapeutic area focus of leading pharmaceutical companies
Royalty recovery and audits
Managing and motivating negotiators
Prepare to meet your partner
Book review and author review
Read more HERE
|
|
Issue 7 – Winter 2008
Partnerships: Necessary but not sufficient for the future of the Pharmaceutical Industry
The perfect business development organisation? Comparison of theory and practice along the pharmaceutical licensing process
The Reverse Start-Up Model: An organisational approach to bridge the innovation gap
Opportunities and challenges in licensing
Creating real value in pharmaceuticals. Driving business development through portfolio strategy
Read more HERE
|
|
Issue 6 – Autumn 2008
Venture Capital and Not for Profit Interaction in Medical Innovation: Establishing an Equitable Solution?
The Changing Face of R&D in the Future Pharmaceutical Landscape
Negotiating Clinical Trials: The Process of Building and Sustaining Trust or How do Cats Share the Milk?
Book reviews
The Art of War Gaming
Read more HERE
|
|
Issue 5 – Spring 2008
PLG news
The interface between the pharmaceutical industry and academia in the UK
Cultural aspects in managing development and marketing alliances
The Pharma Negotiator: a style profile
Negotiating boomerang deals
Opportunities and barriers in the biosimilar market: Evolution or revolution for generics companies?
Read more HERE
|
|
Issue 4 – Autumn 2007
Consolidation in the generics sector
Mind the gap: integrating business development
Communication during cross-cultural negotiations
How inaccurate self-reporting affects your business liability
Competitive intelligence: when ignorance is not bliss
Termination: intellectual property and related issues
Book reviews
Read more HERE
|
|
Issue 3 – Spring 2007
Negotiating performance clauses in licensing contracts
Global pricing strategies for pharmaceutical goods
Drug delivery
Product life-cycle management through second indications – a case study
Data protection for pharmaceuticals in the European Union
‘Mind the gap’: how to negotiate with innovators and scientists
Patent pools – a practical guide
Read more HERE
|
|
Issue 2 – Autumn 2006
The business development professional: an evolving breed
The key to successful collaborations: rigorous and independent due diligence
Equity investments in licensing deals
Co-marketing in Italy: a history of success
Co-ownership of intellectual property rights: a warning for the unwary
How organisations negotiate: managing a love-hate relationship
Life-cycle management under scrutiny
Read more HERE
|
|
Issue 1 – Spring 2006
Issues arising from the TGN1412 clinical trial
IP valuation in pharmaceuticals and biotech
Legal Implications of different licensing structures
Negotiating with the tribes
Licensing opportunities in China’s emerging bio-pharma industry
Building ethical and generic partnering deals in Poland
The great leap for small and medium-sized pharma companies
Read more HERE
|
| |
Order Back Issues HERE
|
